Otolaryngology Online Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 151 808 1136

Commentary - Otolaryngology Online Journal (2022) Volume 12, Issue 9

An endonasal technique to the resection of a papillary seromucinous adenocarcinoma of the Eustacian tube.

Jhang Nauyen*

Division of Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton, AB, Canada

*Corresponding Author:
Jhang Nauyen
Division of Otolaryngology-Head and Neck Surgery
University of Alberta, Edmonton, AB, Canada
E-mail: jhang.nauyen@ualberta.ca

Received: 05-Sep-2022, Manuscript No. JORL-22-75239; Editor assigned: 06-Sep-2022, PreQC No. JORL-22-75239 (PQ); Reviewed: 20-Sep-2022, QC No. JORL-22-75239; Published: 28-Sep-2022, DOI: 10.35841/2250-0359.12.9.293

Visit for more related articles at Otolaryngology Online Journal

Papillary seromucinous adenocarcinoma of the sinonasal tract is exceedingly rare. The goals of this case report are to describe a case of papillary seromucinous adenocarcinoma presenting in the nasopharynx and to check the literature concerning different comparable cases.due to great differences in healthcare shape between the us and Canada, there are specific boundaries to adopting new scientific technology in Canada. In this newsletter, we describe our experience growing a transoral robot surgery (TORS) software at Western college. Specifically, we outline the steps that have been necessary to obtain institutional and multidisciplinary team approval, monetary support, in addition to physician and allied healthcare employee’s education. The nasopharynx bills for much less than 1% of malignancies within the United States of America. The maximum commonplace malignancy in the nasopharynx is Nasopharyngeal Carcinoma (NPC), which is a form of squamous mobile carcinoma (SCC) with a histopathology and behavior precise from SCC originating someplace else inside the head and neck. But, the differential prognosis for a nasopharyngeal mass stays broad. Benign lesions include but are not restrained to juvenile nasal angiofibroma, thornwaldt’s cysts, papillomas, craniopharyngiomas and benign salivary gland tumors. Similarly to NPC, chordomas, lymphoma, hemangiopericytoma, rhabdomyosarcroma and salivary gland tumors represent malignant lesions of the nasopharynx.

A common hassle with nasopharyngeal malignancies is that sufferers can often gift without neighborhood signs; rather their number one tumor might be detected all through the workup of a metastasis to a cervical lymph node. Tumors of the nasopharynx can gift with a commonplace set of lawsuits, usually because of non-specific local effects of the neoplasm. Nasal obstruction may additionally result from mass effects and tumor bleeding can cause epistaxis or hemoptysis. If the tumor obstructs the Eustachian tube, the patient might also increase a center ear effusion with resultant conductive hearing loss and/ or tinnitus. some patients can gift with complications, otalgia or cranial nerve deficits [1].

After several discussions, a protocol assembly become organized to talk about the viable integration of TORS into our present day remedy algorithms. Our overview of modern-day practices revealed that following FDA approval, many facilities in the United States started the usage of TORS because the desired modality of remedy for oropharyngeal and laryngeal cancer such as people with advanced nearby metastases [2]. Most people of these patients nonetheless require submit-operative adjuvant therapy. for you to pick out for patients who could avoid adjuvant therapy totally, our consensus turned into to undertake an extra conservative method, supplying surgery to choose level I-II oropharyngeal and supraglottic cancers. Other eligible patients consist of people with absolute surgical indications, which include T1-2 radiation screw ups and small salivary gland tumors, wherein the treatment opportunity might historically require open surgical procedure. We also evolved evidence-based recommendations for post-operative chemotherapy and radiation following TORS [3].

Papillary seromucinous adenocarcinoma is an unprecedented tumor that could gift inside the nasopharynx. We describe the endoscopic surgical control of one such affected person that offered to our care. This example is exciting as it represents an unprecedented pathological variant of an uncommon nasopharyngeal tumor [4]. Additionally, from the literature, minor salivary gland tumors of the nasopharynx seem like derived from the mucosa of the nasopharynx itself. But, in the case of our patient, the lesion in question was in fact a pedunculated lesion that appeared to originate from within the Eustachian tube. Subsequently, the management of sufferers together with ours remains controversial. Historically surgical resection of nasopharyngeal malignancies has been achieved by an open approach; however this paradigm appears to be evolving. In this case, a minimally invasive resection was finished without a proof of residual sickness. This changed into made feasible via the small length of the lesion and the dearth of invasion of surrounding systems [5].

References

  1. Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, et al (2004) Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15:383–388.

    2. Indexed at, Google Scholar, Cross Ref

  2. Hogikyan ND, Sethuraman G (1999) Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 13:557–569.

    3. Indexed at, Google Scholar, Cross Ref

  3. Abdel Khalek Abdel Razek A, King A (2012) MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol 198:11–18.

    4. Indexed at, Google Scholar, Cross Ref

  4. Eveson JW (2011) Salivary tumours. Periodonto 57:150–159.

    5. Google Scholar

  5. Blount A, Riley KO, Woodworth BA (2011) Juvenile nasopharyngeal angiofibroma. Otolaryngol Clin North Am 44:989–1004.

    6. Indexed at, Google Scholar, Cross Ref

Get the App